E. Burandt

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
E. Burandt, Eike Burandt, E C Burandt, E Burandt, Eike Christian Burandt, Eike C Burandt, E.-c. Burandt, Eike-christian Burandt, Eike C. Burandt
Publication record
254 papers · 4,042 citations · H-index 33

PAPERS

Glucocorticoid Receptor (GR) Expression in Human Tumors: A Tissue Microarray Study on More than 14,000 Tumors
20252 citationsauthor #18
Abstract 100: L1CAM(CD171) can be highly expressed in many tumor types but lacks strong associations with tumor phenotype
20250 citationsauthor #25
Estrogen receptor expression in human tumors: A tissue microarray study evaluating more than 18,000 tumors from 149 different entities.
20254 citationsauthor #22
Abstract 2652: Glucose-transporter 1 (GLUT1) is highly expressed in many tumor types and often linked to tumor progression
20250 citationsauthor #25
Abstract 5144: Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancer
20250 citationsauthor #19
Bericht der Arbeitsgemeinschaft Gynäko- und Mammapathologie der Deutschen Gesellschaft für Pathologie
20250 citationsauthor #1
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype
20250 citationsauthor #18
Stromal PDGFR-beta expression is a prognostic factor in high-grade serous ovarian cancer patients but is it also predictive for response to antiangiogenic treatment?
20251 citationsauthor #5
812 TTF1 Expression is Linked to Adverse Tumor Phenotye and Poor Prognosis in ERG-fusion Positive Prostate Cancers
20250 citationsauthor #10
High-level STING expression in tumour and inflammatory cells is linked to microsatellite instability and favourable tumour parameters in a cohort of over 1,900 colorectal cancer patients.
20250 citationsauthor #21
Abstract 5284: Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: a tissue microarray study on 16,870 tumors
20250 citationsauthor #29
Abstract 6486: Prognostic impact of the immune environment in non-small cell lung cancer
20250 citationsauthor #12
Abstract 99: HMGB1deficiency occurs in a broad range of human cancers and is often associated with unfavorable tumor phenotype
20250 citationsauthor #19
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors
20252 citationsauthor #27
Abstract 3207: TIM-3 expression in human cancer: A tissue microarray study on 17,172 patients
20250 citationsauthor #26
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomy
20251 citationsauthor #11
Correction: High prevalence of p16 staining in malignant tumors
20250 citationsauthor #25
543 CDH16 and CD56 for the Distinction of Neoplastic from Non-neoplastic Thyroid Tissues
20250 citationsauthor #4
1542 Brachyury expression is highly specific for chordoma: A tissue microarray study involving 14,976 cancers from 135 different tumor types and subtypes
20250 citationsauthor #25
3055eP Prevalence and prognostic role of TROP2 expression in prostate cancer
20250 citationsauthor #5
Brachyury expression is highly specific for chordoma: A tissue microarray study involving 14,976 cancers from 135 different tumor types and subtypes.
20253 citationsauthor #24
A Tc1‐ and Th1‐T‐lymphocyte‐rich tumor microenvironment is a hallmark of MSI colorectal cancer
20252 citationsauthor #30
High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancer
20250 citationsauthor #10
Abstract 4652: Prevalence and prognostic role of KDM6A deficiency and overexpression in surgically treated prostate cancer
20250 citationsauthor #5
Abstract 5147: Prognostic role of MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomy
20250 citationsauthor #12
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumors
20250 citationsauthor #30
Expression of Trefoil Factor 1 (TFF1) in Cancer: A Tissue Microarray Study Involving 18,878 Tumors
20246 citationsauthor #25
Prevalence of S-methyl-5′-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer
202412 citationsauthor #16
PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entities
202411 citationsauthor #18
Unveiling breast cancer metastasis through an advanced X-ray imaging approach
20247 citationsauthor #3
PGP9.5 expression in human tumors: A tissue microarray study on 13,920 tumors from 120 different tumor entities.
20241 citationsauthor #21
Epithelial Cell Adhesion Molecule (EpCAM) Expression in Human Tumors: A Comparison with Pan-Cytokeratin and TROP2 in 14,832 Tumors
202412 citationsauthor #23
TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities
202412 citationsauthor #16
Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 Tumors
20244 citationsauthor #17
Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumors.
202413 citationsauthor #21
Abstract 5206: High level STING expression in tumor and inflammatory cells is linked to microsatellite instability and favorable tumor parameters in a cohort of 1,900 colorectal cancer patients
20240 citationsauthor #12
Abstract 1047: Expression of TYMS in cancer: A tissue microarray study involving 6,613 cancers from 127 tumor entities
20240 citationsauthor #18
Steroidogenic Acute Regulatory Protein Is a Useful Marker for Sex-Cord-Stroma Tumors and Normal and Neoplastic Adrenocortical Tissue.
20241 citationsauthor #19
Staining pattern of specific and cross‐reacting Melan‐A antibodies: A comparative study on 15,840 samples from 133 human tumor types
20242 citationsauthor #20
Abstract 3804: Multiparameter cell-cycle measurement enables a better assessment of cancer aggressiveness than Ki67 LI alone
20240 citationsauthor #12
TRPS1 is a Highly Sensitive Marker for Breast Cancer
202411 citationsauthor #20
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, June 2024)
20241 citationsauthor #3
GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the Pancreas
20242 citationsauthor #18
KLK7 expression in human tumors: a tissue microarray study on 13,447 tumors
20243 citationsauthor #20
Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 Tumors
202421 citationsauthor #18
Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities
20244 citationsauthor #29
PAX6 is a useful marker for pancreatic origin of neuroendocrine neoplasms: A tissue microarray study evaluating more than 19,000 tumors from 150 different tumor types.
20245 citationsauthor #21
Detection of Multiple HPV Types in Liquid Biopsies of Cervical Neoplasia.
20246 citationsauthor #11
Abstract 1046: Prevalence of MTAP deficiencyin human cancer: A tissue microarray study on 17,078 cancers from 149 different tumor types
20240 citationsauthor #17
Abstract 6450: High mobility group protein 2 (HMGA2) is highly expressed in a broad range of human cancers
20240 citationsauthor #16
Stimulator of Interferon Genes Protein (STING) Expression in Cancer Cells: A Tissue Microarray Study Evaluating More than 18,000 Tumors from 139 Different Tumor Entities
20247 citationsauthor #26
Prevalence and Significance of AGR2 Expression in Human Cancer
20243 citationsauthor #28
Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer Tissues
20232 citationsauthor #20
Carcinoembryonic antigen (CEA) expression in human tumors: A tissue microarray study on 15,413 tumors.
20235 citationsauthor #13
PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples
202313 citationsauthor #24
Pattern of MUC6 expression across 119 different tumor types: A tissue microarray study on 15 412 tumors
20238 citationsauthor #23
Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors.
202315 citationsauthor #18
Mammaglobin-A Expression Is Highly Specific for Tumors Derived from the Breast, the Female Genital Tract, and the Salivary Gland
202314 citationsauthor #22
Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report about a Male Patient with Pectoral Implants
20230 citationsauthor #5
Prostein expression in human tumors: A tissue microarray study on 19,202 tumors
20230 citationsauthor #5
1219P Artificial intelligence-based breast cancer detection facilitates automated prognosis marker assessment using multiplex fluorescence immunohistochemistry
20230 citationsauthor #6
Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid
20233 citationsauthor #15
Abstract 2164: Patterns of estrogen receptor expression across 18,500 tumor samples obtained from 149 cancer types
20230 citationsauthor #20
Pattern of desmogleins 1 and 3 co-expression in human tumours: a TMA study on 16,100 tumours
20230 citationsauthor #9
Upregulation of TIM3 and reduced expression of PD-1 on immune cell subsets in advanced prostate cancers
20230 citationsauthor #10
Abstract 2212: Prevalence of PGP9.5 expression in human cancers: A TMA study of 14,900 tumors from 148 tumor types
20230 citationsauthor #20
Nonredundant Upregulation of CD112R (PVRIG) and PD-1 on Cytotoxic T Lymphocytes Located in T Cell Nests of Colorectal Cancer.
202310 citationsauthor #22
Abstract P2-11-15: Focal ESR1 gene amplification is an independent prognostic marker in postmenopausal patients with endocrine-responsive early breast cancer
20230 citationsauthor #4
Automated Ki‐67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistry
202325 citationsauthor #17
Diagnostic role and prognostic impact of PSAP immunohistochemistry: A tissue microarray study on 31,358 cancer tissues from 127 different tumor types
20230 citationsauthor #7
High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer
20231 citationsauthor #22
Abstract 6649: Prevalence and spatial interplay of mononuclear phagocyte and lymphocyte subpopulations in 49 carcinoma entities in respect to its TIM3, PD-1, PD-L1 and CTLA-4 expression using BLEACH&STAIN
20230 citationsauthor #16
GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors
202327 citationsauthor #19
Epithelial cell adhesion molecule 1 (EpCAM) expression in human tumours: a comparison with pan-cytokeratin in 11,053 tumours
20230 citationsauthor #10
BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1–driven Immune Phenotypes with Distinct Spatial Orchestration
202310 citationsauthor #23
Impact of HER2 assay sensitivity on the ability to detect tumors with low to ultra-low HER2 expression: A TMA study on more than 10,000 tumors from more than 100 tumor entities.
20230 citationsauthor #20
Abstract 5438: The combination of artificial intelligence and BLEACH&STAIN multiplex fluorescence immunohistochemistry facilitates automated prostate and breast cancer detection
20230 citationsauthor #9
Abstract 5554: Mammaglobin-A expression in highly specific for tumors derived from the breast, the female genital tract and salivary gland tumors
20230 citationsauthor #22
Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry
20232 citationsauthor #27
Abstract 5457: Prevalence of “low” HER2 expression is frequent in breast cancer but also in cancers of other origin: A tissue microarray study on 131 tumor types
20231 citationsauthor #20
Abstract 3302: KLK7 expression in human tumors: A tissue microarray study on 13,447 tumors
20231 citationsauthor #19
CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas
20233 citationsauthor #22
TISSUE-INFILTRATING TH9 CELLS IN HUMAN ENDOMETRIAL CANCER
20230 citationsauthor #9
Abstract 5563: Androgen receptor (AR) is frequently found in human cancers and inversely linked to patient outcome in breast and renal cell carcinomas
20230 citationsauthor #20
Abstract 3303: High homogeneity of mesothelin expressionin primary and metastatic ovarian cancer
20230 citationsauthor #22
Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors
202218 citationsauthor #17
Embryonal Rhabdomyosarcoma of the Uterine Cervix
202214 citationsauthor #4
Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 Tumors
20228 citationsauthor #22
Correction to: MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes
20220 citationsauthor #2
Synaptophysin and chromogranin A expression analysis in human tumors.
202226 citationsauthor #21
High prevalence of p16 staining in malignant tumors
202227 citationsauthor #25
Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells
20226 citationsauthor #12
Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumors.
20225 citationsauthor #19
Villin expression in human tumors: a tissue microarray study on 14,398 tumors
202210 citationsauthor #22
Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumors.
20226 citationsauthor #20
Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors
202277 citationsauthor #22
Morphologic and Molecular Heterogeneity of Cervical Neuroendocrine Neoplasia
20227 citationsauthor #7
Abstract P069: Semi-automated validation and quantification of CTLA-4 in 90 different Tumor entities using multiple antibodies and artificial intelligence
20220 citationsauthor #10
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer.
20222 citationsauthor #19
SATB2 Expression in Human Tumors.
202216 citationsauthor #7

TIMELINE

2007 497 citations

2009 16 citations

2010 307 citations

2011 0 citations

2012 62 citations

2013 363 citations

2014 231 citations

2015 180 citations

2016 134 citations

2017 59 citations

2018 109 citations

2019 384 citations

2020 427 citations

2021 606 citations

2022 378 citations

2023 140 citations

2024 144 citations

2025 15 citations

E. Burandt

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT